173 related articles for article (PubMed ID: 36275722)
21. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
Zheng C; Guo H; Mo Y; Liu G
Recent Pat Anticancer Drug Discov; 2023 Aug; ():. PubMed ID: 37653627
[TBL] [Abstract][Full Text] [Related]
22. A multi-omics-based investigation of the immunological and prognostic impact of necroptosis-related genes in patients with hepatocellular carcinoma.
Yang H; Jiang Q
J Clin Lab Anal; 2022 Apr; 36(4):e24346. PubMed ID: 35293027
[TBL] [Abstract][Full Text] [Related]
23. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
Front Genet; 2022; 13():919638. PubMed ID: 35783277
[No Abstract] [Full Text] [Related]
24. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer.
Zou W; Li L; Wang Z; Jiang N; Wang F; Hu M; Liu R
Bioengineered; 2021 Dec; 12(1):9006-9020. PubMed ID: 34654352
[TBL] [Abstract][Full Text] [Related]
25. Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma.
Xie J; Chen L; Cao Y; Ma C; Zhao W; Li J; Yao W; Hu Y; Wang M; Shi J
Aging (Albany NY); 2023 Mar; 15(6):2082-2096. PubMed ID: 36920166
[TBL] [Abstract][Full Text] [Related]
26. The combined prognostic model of copper-dependent to predict the prognosis of pancreatic cancer.
Guan X; Lu N; Zhang J
Front Genet; 2022; 13():978988. PubMed ID: 36035166
[No Abstract] [Full Text] [Related]
27. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
28. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
29. Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma.
Ren H; Zheng J; Cheng Q; Yang X; Fu Q
Front Genet; 2022; 13():900713. PubMed ID: 35957699
[No Abstract] [Full Text] [Related]
30. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
Xu L; Gao X; Xing J; Guo Z
Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
[TBL] [Abstract][Full Text] [Related]
31. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
Peng YL; Wang LX; Li MY; Liu LP; Li RS
PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
[TBL] [Abstract][Full Text] [Related]
32. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes.
Li Z; Yang W; Liu D; Ye W; Du G; Li X
Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354
[TBL] [Abstract][Full Text] [Related]
33. Construction of a pancreatic cancer prediction model for oxidative stress-related lncRNA.
Huang H; Wei Y; Yao H; Chen M; Sun J
Funct Integr Genomics; 2023 Apr; 23(2):118. PubMed ID: 37020128
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
[TBL] [Abstract][Full Text] [Related]
35. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
36. Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma.
Bao JH; Li JB; Lin HS; Zhang WJ; Guo BY; Li JJ; Fu LM; Sun YP
Anal Cell Pathol (Amst); 2022; 2022():2721005. PubMed ID: 35509814
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
38. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma.
Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A
Front Genet; 2022; 13():916024. PubMed ID: 36110223
[No Abstract] [Full Text] [Related]
39. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer.
Xie J; Tian W; Tang Y; Zou Y; Zheng S; Wu L; Zeng Y; Wu S; Xie X; Xie X
Front Mol Biosci; 2022; 9():834593. PubMed ID: 35601830
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
